Mesenchymal stromal cell therapy for damaged retinal ganglion cells, is gold all that glitters?
Mesenchymal stromal cells are an excellent source of stem cells because they are isolated from adult tissues or perinatal derivatives, avoiding the ethical concerns that encumber embryonic stem cells. In preclinical models, it has been shown that mesenchymal stromal cells have neuroprotective and immunomodulatory properties, both of which are ideal for central nervous system treatment and repair. Here we will review the current literature on mesenchymal stromal cells, focusing on bone marrow mesenchymal stromal cells, adipose-derived mesenchymal stromal cells and mesenchymal stromal cells from the umbilical cord stroma, i.e., Wharton's jelly mesenchymal stromal cells. Finally, we will discuss the use of these cells to alleviate retinal ganglion cell degeneration following axonal trauma.
['Lucas-Ruiz|Fernando|F|', 'Galindo-Romero|Caridad|C|', 'García-Bernal|David|D|', 'Norte-Muñoz|María|M|', 'Rodríguez-Ramírez|Kristy T|KT|', 'Salinas-Navarro|Manuel|M|', 'Millán-Rivero|Jose E|JE|', 'Vidal-Sanz|Manuel|M|', 'Agudo-Barriuso|Marta|M|']
stem cells neuroprotection bone marrow umbilical cord Wharton's jelly adipose stem cells optic nerve axotomy